GBI is a Big Data, Health 2.0 business with supplier facing, physician facing, and consumer facing products. We aim to help actors in the healthcare value chain make better decisions by providing game-changing transparency, tools, and a platform for communication.
Founded in 2002 in Shanghai, GBI is expanding rapidly (Brazil and US in process) and seeking talent for all aspects of our business, particularly in technology and healthcare data.
Supplier facing products include:
-SOURCE - industry intelligence system for pharma management
-METRIX - life scientist intelligence - money flow, publications, research productivity
-NAVIS - segmentation and intelligence tools/CRM for pharma marketing and medical reps
-INTELEX - healthcare legal intelligence
-CPB Review - monthly magazine covering China's pharma and biotech industry
-Consulting - BD consulting for pharma
Pharma facing products include:
-Jibo.cn - website with a clinical reference, news, professional development, and networking opportunities for physicians
-Jibo mobile (Android and iOS) - mobile clinical reference, news and intelligence tool for Chinese physicians
Consumer facing products are in development
China, Healthcare, health 2.0, pharmaceuticals, Business Intelligence, Data, Big data, Drugs, Consulting, market entry, Salesforce Targeting, News, Healthcare Policy, Drug Reimbursement, Drug Pricing, SFDA